MedTrace Logo

A Study to Evaluate Intravaginal Ejaculation Time in Men With and Without Premature Ejaculation

NCT00210678 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1115

Last updated 2012-10-10

No results posted yet for this study

Summary

The purpose of the study is to characterize intravaginal ejaculatory latency time (time between the start of vaginal intercourse and the start of intravaginal ejaculation) in men with and without premature ejaculation (PE) and to assess the validity of patient-reported outcomes.

Conditions

Interventions

BEHAVIORAL

No intervention

No treatment is given to the patients as this is an observational study.

Sponsors & Collaborators

  • Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

    lead INDUSTRY

Principal Investigators

  • Johnson & Johnson Pharmaceutical Research & Development, LLC Clinical Trial · Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-03-31
Primary Completion
2005-09-30
Completion
2005-09-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00210678 on ClinicalTrials.gov